IN SUMMARY: Under no circumstances can or should the US drug approval process come under questioning by the press or patients. This administration has shelved science and replaced it with politics and pseudoscience which endangers us all.
QUICK READ: The Federal Drug Administration’s Office of Prescription Drug Promotion (OPDP) on Wednesday issued the first warning letter specific to paid-search ads since 2014. The FDA said that the search results did not include any fair balance. This is an example of how out of date the FDA’s Office of Prescription Drug Promotion (OPDP) really is.